Skip to main
DBD

DBD Stock Forecast & Price Target

DBD Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Diebold Nixdorf is poised for strong growth, led by its success in the NA retail market and its strong backlog of orders, which should continue to drive revenue and bottom line growth. The company's focus on lean practices and local sourcing strategy will likely contribute to improved margins and cost discipline. With healthy demand for its products and services in both the banking and retail segments and a strong financial outlook, Diebold Nixdorf has the potential to continue generating strong free cash flow and reducing leverage, making it an attractive investment opportunity.

Bears say

Diebold Nixdorf is facing strong competition in both its Banking and Retail segments, as well as ongoing challenges in execution and cost control. While the company's backlog and order entry may be strong currently, concerns remain over the sustainability of its free cash flow generation and margins in the long term. Furthermore, the company's planned phased implementation of AI-driven technology may result in increased efficiencies, but the full impact and timeline of these improvements remains uncertain, making it difficult to have a positive outlook for the stock at this time.

DBD has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Diebold Nixdorf Inc (DBD) Forecast

Analysts have given DBD a Buy based on their latest research and market trends.

According to 2 analysts, DBD has a Buy consensus rating as of Sep 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $100, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $100, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Diebold Nixdorf Inc (DBD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.